How to start a GLP-1 telehealth business in 2026 (semaglutide and tirzepatide)

To start a company selling semaglutide or tirzepatide, you launch a telehealth brand. Licensed clinicians from a clinician network prescribe after an online visit, a licensed pharmacy fills each prescription, and your company runs the brand, site, checkout and patient care around them. You don't need your own pharmacy or medical license. In 2026 the main route is FDA-approved GLP-1s, and some brands add compounded prescriptions from a 503A pharmacy, one patient at a time, when the prescriber documents a significant clinical difference for that patient. thimblehub sets up and runs your checkout, intake, patient and admin portals and site, fully managed, on the clinician network and pharmacy you choose, and introduces both if you need them.

The same steps start any weight loss telehealth company. Many states limit who can own a medical practice, so have a healthcare attorney set up your company structure and check your plan before you sell.

The legal routes for semaglutide and tirzepatide

Your route decides what you can sell, who fills it and what your ads can say.

The 503A route is narrow. FDA considers a compounded drug essentially a copy when it has the same active ingredient at a similar strength, taken the same way, as an approved drug, and semaglutide with added B12 can still count when the strengths sit within 10% of the approved products. A copy is allowed only when the prescriber decides and documents, for that patient, a change that makes a significant difference. FDA says it generally won't act on four or fewer prescriptions of a copy in a month, far below what a brand fills at scale.

503B outsourcing facilities register with FDA and can compound without a prescription for each patient. They can only use a bulk ingredient that's on FDA's 503B bulks list, or make a drug that's in shortage, and semaglutide and tirzepatide meet neither test. Our GLP-1 compliance guide covers how the rules got here.

Claims FDA has flagged in GLP-1 marketing

FDA has sent warning letters to telehealth companies since September 2025, and the wording it cites repeats. Keep these out of your site, ads and checkout:

• "Same active ingredient as" a brand. FDA quoted this line in its September 9, 2025 letter to DirectMeds, and its February 6, 2026 statement says compounded GLP-1s can't be marketed this way.
• "Generic" semaglutide or tirzepatide. Compounded drugs aren't generics. FDA approves generics and doesn't review compounded drugs before they're sold.
• "Clinically proven" for a compounded drug. FDA's February 2026 statement names this claim too.
• "FDA-approved pharmacy." FDA doesn't approve pharmacies or compounders, a point it made in a June 8, 2026 letter.
• Your brand name on a compounded drug, with no qualifier. FDA's March 3, 2026 letters cite compounded drugs sold under a telehealth company's own name in a way that implies it made them.

Paid ads need one more step. Google and Meta both require LegitScript certification for telehealth advertisers that promote prescription drugs, plus each platform's own approval. Your site is built to LegitScript's requirements, and we support your certification with site changes, reviewer access to your portal and answers on how checkout and patient data work. Our LegitScript guide walks through the process.

Steps to launch, and who does each

YYouthimblehubYour networkYour pharmacy

1. 1

   Your route, checked by an attorney

   You pick your route and walk a healthcare attorney through it: your company structure, your launch states, and what your site and ads will say.

2. 2

   A clinician network

   You bring your clinician network, or we introduce one we work with and you agree terms directly. Networks we work with include MDI, OpenLoop, Beluga, Wizlo and Arora, and we connect any other network during setup.

3. 3

   A licensed pharmacy

   You use your network's pharmacy or one you contract, or we introduce one. Compounded prescriptions go only to a state-licensed 503A pharmacy filling them patient by patient.

4. 4

   The clinical protocol

   Your network's clinicians set the protocol: who qualifies, what rules a patient out, and how doses step up. We shape your intake around it.

5. 5

   Your brand, set up and connected

   thimblehub sets up your site, checkout and intake, and patient and admin portals on your brand, your domain and your own payment processor, such as Stripe. Then we connect your network and pharmacy and turn on dispatch.

6. 6

   A test order, together

   You and our team run a test order together, through every step a patient takes, before you go live.

Test orderYour admin portalPaymentWaitingPaidClinical reviewWaitingIn reviewApprovedPharmacyWaitingDispatched

Replay

What we set up for GLP-1 brands, and what we don't

We set up programs that sell FDA-approved GLP-1s, as injections or pills. We also set up lawful 503A programs, where your prescribers document a patient-specific change for each patient and a state-licensed pharmacy fills each prescription. Our GLP-1 stack guide breaks down each layer of a GLP-1 program.

We don't set up:

• Compounded semaglutide or tirzepatide sold as a cheaper Wegovy, Ozempic, Zepbound or Mounjaro.
• Salt forms such as semaglutide sodium or semaglutide acetate. FDA says it knows of no lawful basis for compounding with them.
• Copy, ads or labels that call a compounded drug the same as, or a generic of, an approved one.

If part of your plan sits in a gray area, we'll say so on the first call and point you to an attorney we trust.

Keeping GLP-1 patients on their plan

GLP-1 care runs month after month, so refills are where a brand grows. We built refills on thimblehub to keep patients on plan with little effort from them or your team.

• Refill check-ins. Before each refill, patients answer a short check-in in their portal on how they're doing, side effects and anything that's changed. You choose whether it's required, optional or off. A new pregnancy, a hospital stay or a dose change request is flagged to the clinician.
• Renewals with the dose already proposed. When a prescription runs out of refills or expires, the renewal goes back to your clinician network automatically, with the check-in attached and the next dose proposed from the last approved one. The prescriber makes the call.
• Dose logs. Patients log each dose in the portal and see their plan, their shipments and their care team in one place.
• A save flow. When a patient goes to cancel, the portal asks why and offers a pause or a skipped month that fits the reason.
• Failed cards. The patient updates the card in the portal, and the refill ships once payment clears. Your team sees every held refill in the admin portal's refill queue.

More in how refills work on thimblehub.

How long a GLP-1 launch takes

What one call to thimblehub gets you

Tell us what you want to sell and what you already have. One call covers the rest:

• Your site, checkout and intake, and patient and admin portals, set up and run by us on your brand and your domain.
• Your clinician network and pharmacy connected, or introductions to ones we work with.
• Ad tracking set up with your site, and campaigns run for you if you want them, as an added engagement.
• People we trust for anything we don't do in house, such as legal work and LegitScript prep.
• Your patients, data, domain and payment processor stay yours, and every customer gets a signed BAA.